CoreValve: Survival and Safety Advantages Compared to Open Surgery for Patients with Prior CABG

A new sub-analysis of 226 patients from the CoreValve High Risk Study showed benefits over surgical aortic valve replacement (SAVR) for high risk patients who had received CABG prior to their valve replacement procedure. The primary endpoint of all-cause mortality or major stroke at one-year was 11.4% in the TAVR group vs. 21.8% for SAVR group, and reached significance with a p value of 0.04.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news